The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (£272m) over five years due to the United States' insistence on sensitive information.
This rejection came to light after a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesperson has since clarified that the US was requesting health data for scientific study and profit while was not willing to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for continued talks to find a agreement agreeable to both sides so the nation's vital HIV programme can proceed.
Wider Context
This development follows a similar situation in Kenya, where a high court halted a similar health funding agreement following legal challenges were raised about the security of citizens' medical information.
After resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
According to statements, 16 nations in Africa have so far agreed to similar agreements, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be available to our population should a new disease outbreak emerge."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending structures previously established through the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with future pandemics.
"This framework is intended to ensure that when a country provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to further dialogue with our American counterparts on how future co-operation could be arranged in a way that respects the independence and interests of each country."
Medical Community Reaction
Medical experts said it recognised the official position, but recommended that talks should continue given that a large portion of the country's Aids initiatives depended on international support.
"Where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.
The halted deal emphasises the complex challenges between receiving crucial foreign assistance and safeguarding local interests in an increasingly data-driven world.